New work in mice finds that certain anti-cholesterol drugs can reduce symptoms of disease in brain autoimmune disorders that are akin to human multiple sclerosis. There are also hints as to how the drugs might work.
This is a preview of subscription content, log in via an institution to check access.
References
Youssef, S. et al. Nature 420, 78–84 (2002).
Maron, D. J., Fazio, S. & Linton, M. F. Circulation 101, 207–213 (2000).
Stanislaus, R. Neurosci. Lett. 269, 71–74 (1999).
Ludewig, B. et al. J. Immunol. 166, 3369–3376 (2001).
Kwak, B., Mulhaupt, F., Myit, S. & Mach, F. Nature Med. 6, 1399–1402 (2000).
Weitz-Schmidt, G. et al. Nature Med. 7, 687–692 (2001).
Lanzavecchia, A. & Sallusto, F. Nature Immunol. 2, 487–492 (2001).
Hohlfeld, R. Brain 120, 865–916 (1997).
Steinman, L. J. Exp. Med. 194, F27–F30 (2001).
Cruveilhier, J. Anatomie pathologique du corps humain (Baillière, Paris, 1841).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wekerle, H. Tackling multiple sclerosis. Nature 420, 39–40 (2002). https://doi.org/10.1038/420039a
Issue Date:
DOI: https://doi.org/10.1038/420039a
- Springer Nature Limited
This article is cited by
-
Elaborate interactions between the immune and nervous systems
Nature Immunology (2004)